SAKK SEMI-ANNUAL MEETING
|
|
|
- Paulina Rogers
- 9 years ago
- Views:
Transcription
1 SAKK SEMI-ANNUAL MEETING THURSDAY, NOVEMBER 26, 2015 AND FRIDAY, NOVEMBER 27, 2015 AT THE ZURICH MARRIOTT HOTEL NEUMUEHLEQUAI 42, 8006 ZURICH SAKK COORDINATING CENTER EFFINGERSTRASSE BERNE T F We bring progress to cancer care
2 Welcome WELCOME NOTE Berne, October 2015 Dear friends of SAKK, dear madam or sir, dear colleagues It is our pleasure to invite you to the November semi-annual meeting of the SAKK to be held at the Marriot Hotel at the river banks in Zurich. Please find henceforth the program of the meeting, registration details and other general information is an exceptional year, as we are celebrating the 50 th anniversary of our SAKK network. This is also reflected in the program, as there will be a 50 Years SAKK Symposium. Achievements of the SAKK during the last 50 years will be presented and the balancing act between social media and data protection will be discussed. Afterwards, you are invited to meet friends and relax at the 50 Years ago themed open end SAKK Jubilee Apéro. Consult the program to see what highlight lies ahead! Beside the jubilee program, there will also be many other meetings and presentations offering insights in science and daily practice. Also, our several groups have invited guests to discuss their fields of specialty. For further information, please consult the scientific program. It is our pleasure to draw your attention to the Satellite Symposium organized by Astellas Pharma AG laying the focus on the way to personalized medicine in prostate cancer and informing about new trends in this field. You may access more information in the separate flyer. Traditionally, we are proud to present the SAKK / Amgen research Grant as well as the GIST Award and a preview to the SAKK/Celgene Grant. Last but not least we look forward to the RTFCCR/SAKK/Gateway Cancer Research Grant presented by the Rising Tide Foundation. We will again have two eventful days contributing to bring progress to cancer care and we look forward to welcoming you in Zurich. Sincerely SAKK Coordinating Center Prof. Dr. Beat Thürlimann President Dr. Peter Brauchli CEO SAKK Bern page 2 / 8
3 SCIENTIFIC PROGRAM THURSDAY, NOVEMBER 26, 2015 Scientific Program Registration and Welcome Coffee Time Square, 2 nd fl Joint Meeting: PG Gastro-Intestinal Cancer & Section Surgery ** Co-Chairs: Michael Montemurro, IOSI, Bellinzona Christoph Kettelhack, University Hospital Basel open session with special guest PD Dr. Gunnar Folprecht, Head Oncology, University Hospital of Dresden, Germany EORTC SPECTACOLOR: Update closed session " PG Lymphoma ** Chair: Emanuele Zucca, IOSI, Bellinzona open session closed session " PG Lung Cancer ** Chair: Oliver Gautschi, Cantonal Hospital Luzern open session, with special guest Prof Johan F. Vansteenkiste, University Hospital Gastuisberg, Leuven, Belgium Clinical role of vaccines in NSCLC: where are we going? closed session " Joint Meeting: WG Symptom Control and Palliative Cancer Care & Section Outcomes Research Co-Chair: Florian Strasser, Cantonal Hospital St. Gallen & Konstantin Dedes, University Hospital Zurich Millennium B, 2 nd fl. Index A, ground fl. Sächsilüüte, 4 th fl. Annum, 1 st fl SPOG, closed session in the North Building Index B, ground fl SAKK Info for CRCs and Trial Nurses Chair: Peter Durrer, SAKK WG Sarcoma, closed session only Chair: Christian Rothermundt, Cantonal Hospital St. Gallen RTFCCR/SAKK/Gateway Cancer Research Grant Eveline Mumenthaler, Director Rising Tide Foundation Decade, 1 st fl. Tourbillon, 4 th fl. Main Building Century AB, 2 nd fl Lunch Buffet at Time Square and Millennium Main Building 2 nd fl Section Surgery Chair: Christoph Kettelhack, University Hospital Basel " Active 2 Kick-off Meeting (by invitation only) Chair: Viviane Hess, University Hospital Basel Chrono, 4 th fl. Tourbillon, 4 th fl. SAKK Bern page 3 / 8
4 Section Network Cancer Predisposition Testing and Counselling (open session) Chair: Pierre Chappuis, University Hospital Geneva with special guest Prof Karl Heinimann, Deputy Director Medical Genetics, University Hospital Basel Opportunities and Threats of Next Generation Sequencing (NGS) PG Urogenital Tumors ** Chair: Richard Cathomas, Cantonal Hospital Grisons open session closed session " PG New Anticancer Drugs ** Chair: Markus Joerger, Cantonal Hospital St. Gallen open session closed session " PG Leukemia ** Chair: Georg Stüssi, IOSI, Bellinzona open session, with special guest Prof Mathilde Hunault, CHU Angers, France GRAALL-2014 protocol - Global overview and focus on Asparaginase therapeutic-drug monitoring closed session cont. Scientific Program Index A, ground fl. Millennium B, 2 nd fl. Decade, 1 st fl. Pendulum, 4 th fl NICER, closed session in the North Building Sächsilüüte, 4 th fl Section Radio Oncology, closed session Chair: Ludwig Plasswilm, Cantonal Hospital St. Gallen Satellite Symposium: Astellas Pharma AG On the way to personalized medicine in prostate cancer where do we stand? Click for more information Introduction: Biomarker driven Therapy Decisions in Prostate Cancer Dr med Richard Cathomas, Cantonal Hospital Grisons Tourbillon, 4 th fl. Century AB, 2 nd fl. Landmark Studies on the Treatment of Advanced Prostate Cancer Prof Dr Nick James, Gibbet Hill Campus University of Warwick, UK Predictive Marker Analysis in Prostate Cancer: Current Status and Outlook PD Dr Christian Ruiz, University Hospital Basel Award Ceremonies SAKK / Amgen Research Grant GIST Award Preview Celgene Grant Century AB, 2 nd fl Coffee break at Time Square and Millennium Main Building 2 nd fl. ** open and closed session SAKK Bern page 4 / 8
5 cont. Scientific Program SAKK Symposium 50 Years Century AB, 2 nd fl. Click for more information see 2 nd page Welcome: Laudatio SAKK Review SAKK: Achievements of SAKK PD Dr Roger von Moos, Vice President SAKK Cancer Research Two Future Oriented Antipodes Target Medicine & Markers versus Big Data Prof Dr Vincent Mooser, Prof Dr Ernst Hafen The Balancing Act between Social Media and Data Protection Prof Dr Marcel Salathé, Prof Dr jur Beat Rudin Podium Discussion with All Four Speakers Vision or Reality? Closing Remarks PD Dr Roger von Moos, Vice President SAKK open end Click for more information SAKK Jubilee Apéro «50 years ago» Podium Discussion with Hans-Jörg Senn SAKK Founding Father & SAKK Past-President ( ) Felix Gutzwiller Preventive Physician, Council of States (2007 Oct. 2015) Mathias Seger Ice Hockey Player ZSC Lions & Captain of Swiss National Ice Hockey Team, SAKK Ambassador Moderation: Tanja Gutmann Millennium, 2 nd fl. FRIDAY, NOVEMBER 27, Registration and Welcome Coffee, Main Building Time Square, 2 nd fl WG Melanoma Chair: Reinhard Dummer, University Hospital Zurich WG Gynecological Cancer Chair: Mathias Fehr, Hospital Münsterlingen, Frauenfeld " WG Imaging in Diagnostic and Therapy Monitoring Chair: Johannes Heverhagen, Insel Hospital, Bern WG Head and Neck Cancer Chair: Frank Zimmermann, University Hospital Basel WG Central Nervous System Tumors Chair: Andreas Hottinger, CHUV, Lausanne Coffee break & Lunch Bags pick-up, at Time Square and Millennium PG Breast Cancer ** Chair: Thomas Ruhstaller, Cantonal Hospital St. Gallen open session closed session Century A, 2 nd fl. Millennium B, 2 nd fl. Decade, 1 st fl. Annum, 1 st fl. Century B, 2 nd fl. 2 nd fl. Millennium B, 2 nd fl. ** open and closed session SAKK Bern page 5 / 8
6 General Information INDIVIDUAL MEETING AGEND AS Please make sure to check out the individual meeting agendas of each group which will be available on our website latest two weeks prior to the meeting. FLOORPLAN MARRIOTT SAKK INDUSTRY POOL PRESENCE The following SAKK industry pool members will be present with an information booth: AstraZeneca AG Booth No. 5 Millennium 2 nd fl. Main Building Astellas Pharma AG Booth No. 4 Millennium 2 nd fl. Main Building Baxalta Schweiz AG Booth No. 9 Millennium 2 nd fl. Main Building Bristol Myers Squibb SA Booth No. 12 (Plus) Time Square 2 nd fl. Main Building Celgene GmbH Booth No. 11 (Plus) Time Square 2 nd fl. Main Building Genomic Health Intl Sàrl Booth No. 7 Millennium 2 nd fl. Main Building Novartis Pharma (Schweiz) AG Booth No. 1 Millennium 2 nd fl. Main Building Pierre Fabre (Suisse) SA Booth No. 10 Millennium 2 nd fl. Main Building Roche Pharma (Schweiz) AG Booth No. 3 Millennium 2 nd fl. Main Building Takeda Pharma AG Booth No. 8 Millennium 2 nd fl. Main Building SAKK Bern page 6 / 8
7 General Information SAKK AT A GLANCE Organization Non-profit institution, association, founded in 1965 President Vice-President CEO Members Prof Dr med Beat Thürlimann, Head Physician Breast Center St. Gallen PD Dr med Roger von Moos, Head Physician Oncology/Hematology, Chur Dr sc nat Peter Brauchli Cantonal Hospital Aarau, Cantonal Hospital Baden, University Hospital Basel, University Hospital Berne, Hospital Center Bienne, Cantonal Hospital Fribourg, University Hospital Geneva, Cantonal Hospital Grisons, Clinik Hirslanden Zurich, Cantonal Hospital St. Gallen, Hospital STS Ltd. Thun, Hospital Thurgau AG, IOSI (Istituto Oncologico della Svizzera Italiana) Ticino, Hospital Valais, University Hospital Vaud, Cantonal Hospital Winterthur, Cantonal Hospital Luzern, City Hospital Triemli Zurich, University Hospital Zurich Assoc. Members St. László Teaching Hospital, Budapest, Hungary; Centre Paul Strauss, Strassbourg, France; University Hospitals Freiburg, Freiburg i.b, Germany SAKK Industry Pool Amgen Switzerland AG, ARIAD Pharmaceuticals, Astellas Pharma AG, AstraZeneca AG, Baxalta Schweiz AG, Bayer (Schweiz) AG, Boehringer Ingelheim (Schweiz) GmbH, Bristol-Myers Squibb SA, Celgene GmbH, Eli Lilly (Suisse) SA, Genomic Health Intl Sàrl, Gilead Sciences Switzerland Sàrl, Janssen-Cilag AG, Jazz Pharmaceuticals, Lipomed AG, Merck (Schweiz) AG, MSD Merck-Sharp&Dhome AG, Mundipharma Medical Company, Novartis Pharma (Schweiz) AG, Pfizer AG, PharmaMar S.A., Pierre Fabre Pharma AG, Roche Pharma (Schweiz) AG, Sandoz Pharmaceuticals AG, Sanofi-Aventis (Schweiz) AG, Spectrum Pharmaceuticals, Takeda Pharma AG, Teva Pharma AG, Vifor AG Our sincere thanks go to the members of the SAKK Industry Pool. Without the regular financial support from these pharmaceutical companies it would not be possible to hold the SAKK Semi-Annual Meetings on the current scale! We appreciate your support. NEXT SEMI-ANNUAL MEETINGS 2016: Marriott, ZH 2017: Marriott, ZH 2018: Marriott, ZH 2019: Marriott, ZH June 30/July1 June 29/30 June 28/29 June 27/28 Nov 24/25 Nov 23/24 Nov 22/23 Nov 21/22 Please note, our events always take place in week 26 (June) and week 47 (November). SAKK Bern page 7 / 8
8 GENERAL INFORMATION General Information HOW TO GET THERE The Marriott is in a central location, a mere nine minute stroll along the banks of the river Limmat from Zurich s main train station. You may also use tram N 11 (direction Auzelg) or 14 (direction Seebach) to get to the stop «Beckenhof» two minutes from the hotel. ACCREDITATION The following associations grant credits: SGC-SSC : 15 credits (Thu: 8 pts./fri: 7 pts.) SGR-SSR : 13 credits (Thu: 8 pts./fri: 5 pts.) SGMO : 15 credits (Thu: 9 pts./fri: 6 pts.) SGH-SSH : 5.5 credits (Thu: 4 pts./fri: 1.5 pts.) SRO-SSRO:16 credits (4 pts. per half-day) PARKING The hotel has its own parking at CHF 4/h or CHF 24 for the day. You may also use the parking Sihlquai in in the vicinity of the hotel. REGISTRATION By Friday, November 16, 2015 Online at or by to [email protected] ORGANIZATION SAKK Coordinating Center Effingerstrasse Bern T F Contact: Iris Meyer & Caroline Kaminski Event Managers T Tram stop 11,14 Marriott Sihlquai 41, 8005 Zurich SAKK Bern page 8 / 8
SAKK SEMI-ANNUAL MEETING
SAKK SEMI-ANNUAL MEETING THURSDAY, JUNE 25, 2015 AND FRIDAY, JUNE 26, 2015 AT THE ZURICH MARRIOTT HOTEL NEUMUEHLEQUAI 42, 8006 ZURICH SAKK COORDINATING CENTER EFFINGERSTRASSE 40 3008 BERNE T +41 31 389
7 th SSHO 2016. Invitation to the. 7 th Swiss Summit on Hemato-Oncology
7 th Swiss Summit on Hemato-Oncology 7 th SSHO 2016 Invitation to the 7 th Swiss Summit on Hemato-Oncology Lucerne Thursday, 7 th April 2016, 15:30 19:00 CME credits will be applied for Swiss Summit on
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium
«THE GENERALISTS AND SPECIALISTS FOR COMPLEX PROJECTS FROM DESIGN TO HANDOVER.»
Profile «THE GENERALISTS AND SPECIALISTS FOR COMPLEX PROJECTS FROM DESIGN TO HANDOVER.» ARCHITECTS AND GENERAL PLANNERS. SINCE 1922. PROJECT MANAGEMENT We plan, monitor and control the entire process from
CHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
BREAST CANCER IN YOUNG WOMEN. OCTOBER 9 th 2015 Aula Magna UNIVERSITÀ DELLA SVIZZERA ITALIANA Lugano
Centro di Senologia della Svizzera Italiana 8 th Edition BREAST CANCER IN YOUNG WOMEN OCTOBER 9 th Aula Magna UNIVERSITÀ DELLA SVIZZERA ITALIANA Lugano Scientific Coordinators: Olivia Pagani and Alberto
OPEN Regional Meeting June 26 and June 27, 2015 Hyatt Regency Pier Sixty Six 2301 Southeast 17th Street Fort Lauderdale, Florida, 33316 AGENDA
OPEN Regional Meeting June 26 and June 27, 2015 Hyatt Regency Pier Sixty Six 2301 Southeast 17th Street Fort Lauderdale, Florida, 33316 Friday, June 26 AGENDA 10:00 am - 10:45 am Registration; Breakfast
EU Clinical Trials Register
EU Clinical Trials Register Sponsor Contact Information Abbott Laboratories Ltd Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE UK Telephone number +44 1628 644475 [email protected]
Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics
Cancer Research in Switzerland
Cancer Research in Switzerland A publication of the Swiss Cancer Research foundation, the Swiss Cancer League and the cantonal cancer leagues on their funded research projects 2013 Edition 2014 Imprint
STATE OF THE ART INVITATION SATURDAY, JANUARY 30 TH, 2016 COMORBIDITIES AND ENVIRONMENTAL FACTORS INFLUENCING MULTIPLE SCLEROSIS
18 TH STATE OF THE ART SYMPOSIUM of the Swiss Multiple Sclerosis Society www.multiplesklerose.ch INVITATION SATURDAY, JANUARY 30 TH, 2016 KKL Luzern, Culture and Convention Centre COMORBIDITIES AND ENVIRONMENTAL
Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015
Brochure More information from http://www.researchandmarkets.com/reports/3398017/ Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Description: Small-Cell Lung Cancer Global Clinical Trials
ONCOLOGY NURSING 7 TH ESO-EONS MASTERCLASS IN. 8-13 March 2014 Ermatingen (Lake Constance) Switzerland MASTERCLASS
MASTERCLASS Photo: Turm by Stephan Balkenhol - A Sculpture for Wolfsberg Photographer: Ralph Feiner, Architekturfotografie, Malans 7 TH ESO-EONS MASTERCLASS IN ONCOLOGY NURSING 8-13 March 2014 Ermatingen
ehealthinsight Series: Online Patient Recruitment Strategies
A Datamonitor report ehealthinsight Series: Online Patient Recruitment Strategies Published: May-08 Product Code: Providing you with: Overview of benefits and drawbacks of online Analysis of online patient
CURRICULUM VITAE. Paul Magnus Schneider, M.D. Professor of Surgery
CURRICULUM VITAE Paul Magnus Schneider, M.D. Professor of Surgery OFFICE Department of Visceral and Transplantation Surgery University Hospital Zurich CH-8008 Zurich Switzerland phone: +41-(0)44-2559723
APV/IPEC Europe Excipient Conference 2014
APV/IPEC Europe Excipient Conference 2014 An update on regulatory and application developments 23 to 24 September 2014 Düsseldorf, Germany Course No. 3128 Marketing Düsseldorf Target Group This conference
INTERPRETING CLINICAL DATA: Highlights From ASCO 2016
INTERPRETING CLINICAL DATA: Highlights From ASCO 2016 SATURDAY, JUNE 25, 2016 Detroit Marriott - Troy, MI AGENDA Time Topic Speaker 7:30 am Registration and Continental Breakfast 8:00 am Opening Remarks/Welcome
30-31. Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens
Advancesincancer immunologyand immunotherapy 30-31 October2015 Royal Olympic Hotel Athens announcement Organizer Hellenic Oncology Research Group (HORG) Symposium chairs N. Kentepozidis, A. Kotsakis, M.
Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct
Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:
KOL Insight: Non-small cell lung cancer Game changing immunotherapies to revolutionise treatment
March 2014 KOL Insight: Non-small cell lung cancer A FirstWord Therapy Trends Report KOL Insight: Lung Cancer Published March 2014 Copyright 2014 Doctor s Guide Publishing Limited All rights reserved.
Direct Democracy: a distinctive feature
12 Direct Democracy: a distinctive feature of Switzerland National Council elections every four years, plus four annual dates for popular votes, and it is not uncommon for additional votes to be held at
PERSONALIZED CANCER TREATMENT A multidisciplinary event
PERSONALIZED CANCER TREATMENT A multidisciplinary event Free Access to the Scientific Sessions March 20 th - 21 st 2015 La Vague de Saint-Paul Saint-Paul de Vence, France Crédit photo Office de Tourisme
Groundbreaking Collaborative Clinical Trial Launched
Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)
PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14
PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14 March 5-6, 2014 Princeton, NJ The Nassau Inn Identify, Prioritize and Solve Key Operational Challenges that Shape the Customer Experience in Pharma GOLD SPONSORS
CONSORTIUM OF SWISS ACADEMIC LIBRARIES
CONSORTIUM OF SWISS ACADEMIC LIBRARIES Beyond Licensing? Library Consortia in the Digital Age Symposium on the occasion of the 10 th anniversary of the Consortium of Swiss Academic Libraries, Zurich, december
16 TH -17 TH INNOVATIONS IN ONCOLOGY NOVEMBER HEIDELBERG
16 TH -17 TH 2015 NOVEMBER INNOVATIONS IN ONCOLOGY HEIDELBERG INNOVATIONS IN ONCOLOGY HEIDELBERG, NOVEMBER 16 TH - 17 TH 2015 German Cancer Research Center (DKFZ) Heidelberg - Germany Hosted by the National
SWISS SOCIETY FOR BIOMATERIALS AND REGENERATIVE MEDICINE NEWSLETTER
President: Dr. Paul-Henri Vallotton, Vice President: Dr. Katharina Maniura, Treasurer: Dr. Giancarlo Rizzoli, Secretary: Dr. Christine Wandrey, http://ssb.biomaterials.ch SWISS SOCIETY FOR BIOMATERIALS
Cancer Research in Switzerland
Cancer Research in Switzerland A publication of the Cancer Research Switzerland foundation, the Swiss Cancer League and the cantonal cancer leagues on their funded research projects 2011 Edition 2012 Imprint
Cancer Research in Switzerland
Cancer Research in Switzerland A publication of the Swiss Cancer Research foundation, the Swiss Cancer League and the cantonal cancer leagues on their funded research projects 2012 Edition 2013 Imprint
Dr. Donald A. Keller, Direktor Regionalplanung Zürich und Umgebung RZU
METREX in Wroclaw, SEP19, 2009: Switzerland and Zurich Dr. Donald A. Keller, Direktor Overview 1. Introduction 2. The political conception of spatial planning in Switzerland 3. The Swiss federal policy
Ask Us About Clinical Trials
Ask Us About Clinical Trials Clinical Trials and You. Our specialists and researchers are at the forefront of their fields and are leading the way in developing new therapies and procedures for diagnosing
Notice of Annual General Meeting
Basel, February 3, 2014 To the shareholders of Novartis AG Notice of Annual General Meeting Date: Tuesday, February 25, 2014, 10.00 a.m. (doors open at 8.30 a.m.) Place: St. Jakobshalle, Basel (entrance
I wish you an inspiring and successful learning experience here in Saint Petersburg. Yours Sincerely, Rachel Clark CEO, EXCEMED
Dear participant, A warm welcome to the "Advanced worshop in Embriology" event. I would like to inform you that as of 28 April 2014 the name of our Foundation changed to EXCEMED Excellence in Medical Education.
Pharmaceutical industry: 2020 and beyond. Driving prosperity, growth, and competitiveness in Switzerland
Pharmaceutical industry: 2020 and beyond Driving prosperity, growth, and competitiveness in Switzerland www.interpharma.ch Pharmaceutical industry: 2020 and beyond Driving prosperity, growth, and competitiveness
Clinical trial research agreement Agreed schedule 4 or 7 clause amendments
Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Medicines Australia and Medical Technology Association of Australia templates The sponsors in the table have agreed clauses for
AUSTRIAN KNEE SYMPOSIUM Sports Medicine Traumatology Prostheses Level: Advanced
AUSTRIAN KNEE SYMPOSIUM Sports Medicine Traumatology Prostheses Level: Advanced June 11 12, 2015 Vienna, Orthopaedic Hospital Speising Chair: Prim. Univ.-Prof. Dr. Martin Dominkus AGENDA 2 DePuy Synthes
The Importance of the Pharmaceutical Industry for Switzerland
Study on behalf of Interpharma The Importance of the Pharmaceutical Industry for Switzerland BAK Basel Economics Michael Grass, Samuel Mösle In collaboration with Polynomics Published by: Interpharma,
Scientific Programme
Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo Cristiana Sessa Istituto Oncologico
Press Release Swiss Arbeitgeber Award 2015
Press Release Swiss Arbeitgeber Award 2015 Occasion: Presentation of the Swiss Arbeitgeber Award 2015 Thursday, 17 September 2015, 6:30 pm, Hotel Marriott Zurich Organiser: icommit GmbH, Poststrasse 35,
Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)
A Datamonitor report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) Published: Oct 07 Product Code: DMTC2133 Providing you with: Identifies which technology vendors
December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES
December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES by Dennis van Rooij with Tim van Tongeren EXECUTIVE SUMMARY More than half of pharma marketers don t or can t leverage
INCENTIVE COMPENSATION CONFERENCE
Announcing the 2nd Annual ZS Associates INCENTIVE COMPENSATION CONFERENCE 08 September 23 24, 2008 Philadelphia, PA Incentive compensation greatly affects sales force motivation and morale. When designed
Villejuif, Paris, France
SCIENTIFIC PROGRAMME 2014 Preceptorships in oncology Aim This live educational preceptorship aims to highlight the crucial role of the multidisciplinary approach in diagnosis, treatment and management
USD 1,500,000 for cancer researchers in Switzerland and Spain
Press release SAKK/RTFCCR/Gateway Research Grant: Winning studies announced USD 1,500,000 for cancer researchers in Switzerland and Spain Five researchers were awarded with the SAKK/RTFCCR/Gateway Research
Room for your success
Room for your success Welcome to the InnovationTower. An attractive office building that combines modern architecture with green building standards is being built in at the intersection of German-speaking
ROOT CAUSE ANALYSIS. Prevent Non-Compliance and Achieve Successful Root Cause Analyses and CAPA Systems Implementation from Clinical to Post-Market
5th SIGNAL DETECTION, ROOT CAUSE ANALYSIS & January 22-23, 2015 Key Bridge Marriott Arlington, VA Prevent Non-Compliance and Achieve Successful Root Cause Analyses and CAPA Systems Implementation from
BIG DATA Driving Evidence for Healthcare Thursday, 5 March 2015 13:30 17:45 Lecture Hall Pathology C
Symposium of the Swiss-Austrian ISOP Chapter International Society of Pharmacovigilance BIG DATA Driving Evidence for Healthcare Thursday, 5 March 2015 13:30 17:45 Lecture Hall Pathology C Program: Thursday,
3 rd SSIPM Congress. December 2-3, 2011 Montreux. Swiss Society for Interventional Pain Management Swiss Neuromodulation Society PROGRAMME
3 rd SSIPM Congress December 2-3, 2011 Montreux Swiss Society for Interventional Pain Management Swiss Neuromodulation Society PROGRAMME Impact of pain research on daily practice: change your routine Table
CNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010
CNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010 Organisers S. Gail Eckhardt, University of Colorado Denver, Aurora, USA Roy S. Herbst, The University of Texas MD Anderson
Annual Press Conference 2012. Business Year 2011
Business Year 2011 Highlights of the Business Year 2011 Andreas Barner Chairman of the Board of Managing Directors Corporate Board Division Pharma Research, Development and Medicine Value through Innovation
17th Annual Continuing Medical Education Conference
17th Annual Continuing Medical Education Conference Register Register online: online: http://radiologists.ab.ca/sponsor-registration http://radiologists.ab.ca/attendee-registration For For more more information
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors
Friday 29 th, October 2010
Friday 29 th, October 2010 15:00-17:00 Registration 17:00-18:00 Opening Ceremony 18:00-18:30 Refreshment Break 18:30-19:00 Plenary Lecture I Nazli Gad El Mawla Memorial Lecture Chairpersons: Prof. Dr.
Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive pressures through to 2019
Brochure More information from http://www.researchandmarkets.com/reports/1314569/ Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive
Curriculum Vitae of Luca Gianni
Education: 1976: State University of Milan, Milan, Italy: Medical Doctor with honors 1981: State University of Milan, Milan, Italy: Board- Certified in Internal Medicine Brief Chronology of Activities
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Wednesday Oct 7th, 2015 Congress Center (Hörsaal 1 3) Marien Hospital Herne Accreditation by the Medical Chamber
European Post-Merger Integration Survey February 2010
European Post-Merger Integration Survey February 2010 Survey purpose and approach The purpose of this survey is to show drivers and barriers as well as keys to success in the post-merger integration process
KEEPING CLINICAL TRIALS IN AUSTRALIA
OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought
Curriculum Vitae - Sara Gandini
Curriculum Vitae - Sara Gandini Academic information 2004 PHD IN CANCER STUDIES at the University of Birmingham (Public Health), UK. Thesis: Meta-Analysis in Cancer Epidemiology. 1995 MASTER OF SCIENCE
50 Years SAKK. Active Against Cancer!
50 Years SAKK Active Against Cancer! Editing: Theres Kummer, Claudia Herren, Marina Stouraitis Translations: IT SA Translations Layout: Tipografia Cavalli, Tenero Print: Tipografia Cavalli, Tenero An online
The Human Right to Science: New Directions for Human Rights in Science
The Human Right to Science: New Directions for Human Rights in Science International Conference Friday, 22 May 2015 Haus der Universität, Schlösslistrasse 5, Berne Switzerland The Swiss Academies of Arts
Ending cancer. Together.
Ending cancer. Together. Making History by Being First To achieve something as big and bold as ending cancer requires the courage to be first and a willingness to partner with others. At the Robert W.
TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...
CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and
Guide. Astellas Pharma US, Inc. XTANDI Access Services SM 2015 NCCN Virtual Reimbursement Resource Room. NCCN.org/reimbursement
Astellas Pharma US, Inc. XTANDI Access Services SM 2015 NCCN Virtual Reimbursement Resource Room Guide The oncology reimbursement landscape continues to present ever-evolving challenges for clinicians
Metastatic Breast Cancer - Pipeline Review, Q1 2011
Brochure More information from http://www.researchandmarkets.com/reports/1524592/ Metastatic Breast Cancer - Pipeline Review, Q1 2011 Description: Metastatic Breast Cancer - Pipeline Review, Q1 2011 Summary
Main Conference Agenda
Sponsored by: (Co-located with Bioequivalence: Intersection between Science & Regulatory Conference) Main Conference Agenda Day One Wednesday, November 5 th, 2014 7:30 Registration Opens & Continental
Roots Analysis Pvt. Ltd.
Roots Analysis Pvt. Ltd. http://www.marketresearch.com/rootsanalysispvt.ltd. -v3981/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am
Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer
Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer For more visit ResearchToPractice.com/5MJC CME INFORMATION OVERVIEW OF ACTIVITY Each year, thousands of clinicians and basic scientists
Rx-360 An International Pharmaceutical Supply Chain Consortium
Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)
With the project we hope to bring enhanced treatment for better care of our patients who will no
HKSH Symposium to Explore New Frontiers in Cancer Management Experience Sharing by Local and Overseas Experts HKSH Hopes to Introduce Proton Therapy Soon (15 June 2014, Hong Kong) A panel of renowned experts
Employees Employees as at 31 August 53 44 20.5 Employees average during the reporting period 52 44 18.2
9M 2007 9M 2006 Change in % Earnings key figures in EUR 000 Other operating income 2,158 966 123.4 Operating expenses (19,486) (13,149) 48.2 of which research and development (16,606) (10,527) 57.8 Operating
MDC CareerDay April 16, 2015 PROGRAM
FOYER, MDC.C 8:30 9:00 REGISTRATION 9:00 9:15 OPENING AND WELCOME Prof. Dr. Gary Lewin Chairman of the Scientific Council, Max Delbrück Center for Molecular Medicine (MDC) 1 9:15 10:00 KEYNOTE TALK I:
The Middle East and the booming Gulf Cooperation Council Thursday, 25 January 2007
2nd Forum Event Executive MBA University of Zurich The Middle East and the booming Gulf Cooperation Council Thursday, 25 January 2007 Zurich Development Center / University of Zurich Auditorium Main event
2 nd GERMAN-AFRICAN HEALTHCARE SYMPOSIUM
2 nd GERMAN-AFRICAN HEALTHCARE SYMPOSIUM Berlin, 14 th October 2015 Preliminary Program Venue: Karl Storz GmbH & Co. KG, Scharnhorststr. 3, 10115 Berlin With support of: www.healthafrica.de Alterations
5 th Heidelberg Myeloma Workshop
Scientific program 5 th Heidelberg Myeloma Workshop Current status and developments in diagnosis and therapy of Multiple Myeloma Congress venue: Lecture hall, Hospital for Internal Medicine Friday, 24
The Evolution of Data Platforms in IMI. Anthony Rowe, Janssen R&D IT 08 April 2016 Med-e-Tel Luxembourg
The Evolution of Data Platforms in IMI Anthony Rowe, Janssen R&D IT 08 April 2016 Med-e-Tel Luxembourg Three trends in technology today Ubiquity of the Internet Three trends in technology today Ubiquity
ORGANIZERS Fundación para la Investigación Médica Aplicada FIMA Clínica Universidad de Navarra CUN
D International Symposium: Immunostimulatory monoclonal antibodies and immunomodulation: harvesting the crop Fundación Ramón Areces GENERAL INFORMATION DATES OCTOBER 18th 20th VENUE University of Navarra.
Medical Writing Takes Off in India
Visit http://store.centerwatch.com to learn more about State of the Clinical Trials Industry 2008 Special Article Reprint For the latest news and views on the clinical trials industry visit ClinicalTrialsToday.com
Corporate culture vs. National culture
presents: Corporate culture vs. National culture Positive aspects while trading with Latin America What are the most important traits coming from the Latin American culture that impact performance of the
Pharmaceutical Products Liability. Michael C. Dubin Stephen Knobloch
Pharmaceutical Products Liability Michael C. Dubin Stephen Knobloch Objectives Objective 1 Get Actuaries Thinking About Adding Value to New Areas Objective 2 Provide example using pharmaceutical industry
Certificate of Banking & Insurance
Certificate of Banking & Insurance Presentation of the Course and the School of Business Administration in Fribourg / Switzerland $ $ $ $ $ $ $ $ $ $ Prof. Dr. Olaf Meyer Deputy Head of School of Business
REGISTER OF INTERESTS SIGN guideline: Management of patients with chronic non-malignant pain Published: 28 November 2013
CHAIR Lesley Colvin, Consultant Anaesthetist/Senior Lecturer Financial Non-financial Non-personal Last updated Specific Non-Specific Specific Non-Specific Consultancy lecturing Pfizer. Medicine educational
WORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region
WORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region April 2016 27-30 Santiago - Chile Hotel Diego de Almagro San Pío X 2530, Providencia, Santiago. INFORMATION www.lungcancerworkshop.cl
International Symposium on Malignant Pleural Mesothelioma
International Symposium on Malignant Pleural Mesothelioma LONDON 2015 Friday 6th & Saturday 7th November 2015 Jumeirah Carlton Tower Hotel Cadogan Place Knightsbridge London SW1X 9PY United Kingdom Dear
